Landgren Breaks Down the Benefit of Novel Quadruplet in Newly Diagnosed Myeloma
Season 5, Episode 12, May 31, 2021, 06:50 PM
Dr. Landgren discusses the potential of a quadruplet regimen comprised of carfilzomib, lenalidomide, dexamethasone, and daratumumab in the treatment of patients with newly diagnosed multiple myeloma.